# FDA recall D-0168-2017

> **Nationwide Laboratories, LLC** · Class II · drug recall initiated 2016-10-28.

## Product

Phenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey  08830, NDC 42937-702-10.

## Reason for recall

CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

## Distribution

Nationwide in USA and Puerto Rico

## Key facts

- **Recall number:** D-0168-2017
- **Recalling firm:** Nationwide Laboratories, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-10-28
- **Report date:** 2016-12-07
- **Termination date:** 2018-05-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Iselin, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0168-2017

## Citation

> AI Analytics. FDA recall D-0168-2017. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-0168-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*